Implementation of novel and conventional outbreak control measures in managing COVID-19 outbreaks in a large UK prisonby WEPHREN
Infection prevention and control and surveillance for coronavirus disease (COVID-19) in prisons in EU/EEA countries and the UKby WEPHREN
EMCDDA Trendspotter briefing: impact of COVID-19 on patterns of drug use and drug-related harms in Europeby WEPHREN
COVID-19 GUIDANCE FOR HEALTHCARE IN SECURE ENVIRONMENTS Recovery, Renewal, Resilience: June 2021 Practical advice for cliniciansby WEPHREN
Covid-19: Council of Europe anti-torture Committee issues “Statement of principles relating to the treatment of persons deprived of their liberty”by WEPHREN
Vaccination strategy against Sars-Cov-2 - Role of socio-economic and occupational factors in the risk of infection and severe forms of Covid-19 and updating of recommendationsby WEPHREN
Interim Guidance on Management of Coronavirus Disease 2019 (COVID-19) in Correctional and Detention Facilitiesby WEPHREN
Good practices in managing infectious diseases in prison settings: a snapspot of responses to COVID-19 implemented around the globe between May and September 2020 (2022)by WEPHREN
This is the first in a series of publications in which report findings the Impact-C19P project which examines how Covid-19 impacted on the delivery and receipt of prison healthcare. Find out more about Impact-C19P here
With over 11 million people incarcerated globally, prevention and control of COVID-19 in custodial settings is a critical component of the public health response. Given the risk of rapid transmission in these settings, it is important to know what guidance existed for responding to COVID-19 in the early stages of the pandemic. We sought to identify, collate, and summarise guidance for the prevention and control of COVID-19 in custodial settings in the first six months of 2020.
Outbreak of SARS-CoV-2 B.1.617.2 (Delta) Variant Infections Among Incarcerated Persons in a Federal Prison — Texas, July–August 2021by WEPHREN
During a COVID-19 outbreak involving the Delta variant in a highly vaccinated incarcerated population, transmission rates were high, even among vaccinated persons.